Dr. Gadbaw is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
OfficeNovartis Pharmaceutical Corporation
1 Health Plaza
East Hanover, NJ 07936
- Is this information wrong?
Education & Training
- University of WisconsinFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- University of WisconsinResidency, Pediatrics, 2004 - 2007
- Michigan State University College Human MedicineClass of 2004
Certifications & Licensure
- WI State Medical License 2005 - 2011
Publications & Presentations
- 13 citationsEfficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.Jean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, Güray Saydam, Tamás Masszi, Simon Durrant, Francesco Passamonti, Mark M. Jones, Hui-Ling Zhen, Jingjin...> ;Annals of Hematology. 2018 Feb 2
- 28 citationsRuxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.Madan Jagasia, Robert Zeiser, Michael C. Arbushites, Patricia Delaite, Brian Gadbaw, Nikolas von Bubnoff> ;Immunotherapy. 2018 Jan 10
- 8 citationsEfficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a studyAli T. Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyère Mahuzier, Brian...> ;Blood. 2018 Jan 11
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: